Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

LMWH and LDA

Preclinical

MMount Sinai Hospital, Canada

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

HeartRecruiting

HeartPreclinical

Recruiting

Timeline

Expected Milestones

Q4 2030

PreclinicalRecruiting

Heart

NCT07658989

Clinical

Trials by Indication[1]

Heart1 trial

A Prospective Multicenter Cohort Pilot Study Comparing Antithrombotic Regimens in Pregnancies With Mechanical Heart Valves

Recruiting·MMount Sinai Hospital, Canada·Preclinical·NCT07658989·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for LMWH and LDA. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for LMWH and LDA. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Mount Sinai Hospital, Canada company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: MMount Sinai Hospital, Canada

Related News